Together for Short Lives
Call the Helpline 0808 8088 100

Clinical management of Krabbe disease

Journal title
Journal of neuroscience research
Publication year
2016
Author(s)
Escolar, M. L.; West, T.; Dallavecchia, A.; Poe, M. D.; LaPoint, K.
Pages
1118-25
Volume
94
Number
11

Krabbe disease (KD) is a rare neurodegenerative disorder caused by mutations in the gene encoding the galactocerebrosidase enzyme. The early- and late-infantile subtypes, which are the most common forms of the disease, are rapidly progressive and lead to early death, whereas the later-onset types are clinically heterogeneous. The only disease-modifying treatment currently available is hematopoietic stem cell transplantation, which is effective only when performed early in the course of the disease. Because most patients with KD are diagnosed too late for treatment, primary care physicians are faced with the challenge of caring for a child with severe neurologic impairment. This Review describes presenting symptoms, diagnosis, and disease manifestations of KD and provides basic guidelines for its management. Symptomatic treatment and supportive care that address the unique requirements of these patients can greatly improve the quality of life of patients and their families. (c) 2016 Wiley Periodicals, Inc.

Research abstracts